Skip to main content
. 2023 Feb 6;23:33. doi: 10.1186/s12902-023-01286-6

Table 2.

Summary of meta-analysis outcomes

Outcome No. of studies No. of participants Type of meta-analysis Effect estimate (95% CI) P value I2 (%) Egger's test (P value)
Total Testosterone 3 179 WMD (fixed) -0.14,0.11 0.767 31.8 0.991
SHBG 3 179 WMD (fixed) 0.32,19.18 0.043 0.0 0.075
HOMA-IR 3 189 WMD (random) -1.12,0.37 0.326 53.3 0.687
BMI 5 270 WMD (fixed) -1.32,0.31 0.227 0.0 0.182
Weight 4 206 WMD (fixed) -3.25,1.54 0.485 0.0 0.588
NO 2 124 WMD (random) -8.78,5.31 0.630 69.9 \
TAC 2 124 WMD (fixed) 65.24,147.18  ≤ 0.001 0.0 \
GSH 2 124 WMD (random) -39.30,91.68 0.433 64.1 \
MDA 2 124 WMD (random) -1.16,0.43 0.373 54.3 \
LDL 2 136 SMD (fixed) -0.49,0.18 0.359 0.0 \
HDL 2 136 SMD (fixed) -0.48,0.19 0.405 0.0 \
Triglycerides 2 136 SMD (random) -0.84,0.62 0.769 78.6 \
FPG 2 123 SMD (random) -1.38,0.90 0.678 89.7 \

Values are mean ± SD; (s): selenium group (c): control group;